RAT OVARIAN INSULIN-LIKE GROWTH FACTOR I (IGF-I) GENE EXPRESSION IS GRANULOSA CELL-SELECTIVE: 5′-UNTRANSLATED mRNA VARIANT REPRESENTATION AND HORMONAL REGULATION
- 1 July 1989
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 125 (1), 572-574
- https://doi.org/10.1210/endo-125-1-572
Abstract
We, and others, have recently that the ovary is a site of insulin-like growth factor (IGF)I gene expression. It was the objective of the present studies to assess the relative ovarian abundance of IGF-I transcripts with alternative 5''-untranslated (UT) regions, their cellular localization, and hormonal regulation. To this end, a solution hybridization/RNase protection assay was employed wherein total rat ovarian RNA was hybridized with a 404-base 32P-labelled rat IGF-I riboprobe corresponding to the Class A 5''UT variant. As in liver, three protected bands [322 (Class A), 297 (class B), and 242 (Class C) bases long] were noted, in keeping with established alternative 5'' UT transcripts. The ovarian (as the hepatic) Class C variant proved the most abundant. The ovarian Class B variant was barely detectable. Cellular localization studies revealed these ovarian IGF-I transcripts to be primarily, if not exclusively, of granulosa but not theca-interstitial cell origin. Treatment of immature (21-23 days old) hypophysectomized rats with diethylstilbestrol (DES)-containing subcutaneous silastic implant for a total of 5 days resulted in a 2-fold increase in the (densitometrically quantified) abundance of ovarian IGF-I transcripts, a diametrically-opposed effect (2.6-fold decrease) being noted at the level of the liver. Whereas treatment of hypophysectomized rats with oGH by itself (150 .mu.g, qd, sc x5 days) resulted in a 5-fold increase in hepatic IGF-I gene expression, a limited, albeit distinct inhibitory effect was observed on the steady-state levels of ovarian IGF-I mRNA. In contrast, combined treatment with oGH and DES yielded a 3-fold increase in the abundance of ovarian IGF-I transcripts, there being no net alteration in hepatic IGF-l gene expression. Taken together, these findings reveal ovarian expression of the 3 known 5''-UT IGF-I mRNA variants, document the granulosa cell as the main somatic ovarian cell of IGF-I mRNA generation, and indicate that hepatic and ovarian IGF-I gene expression are differentially regulated in diametrically opposed directions.This publication has 15 references indexed in Scilit:
- Concomitant Effects of Growth Hormone on Secretion of Insulin-Like Growth Factor I and Progesterone by Cultured Porcine Granulosa Cells*Endocrinology, 1987
- Estrogen Induces Insulin—Like Growth Factor—I Expression in the Rat UterusMolecular Endocrinology, 1987
- Cellular Localization of Somatomedin (Insulin-Like Growth Factor) Messenger RNA in the Human FetusScience, 1987
- Tissue Distribution of Insulin-Like Growth Factor I and II Messenger Ribonucleic Acid in the Adult Rat*Endocrinology, 1987
- Molecular Cloning of Rat Insulin-Like Growth Factor I Complementary Deoxyribonucleic Acids: Differential Messenger Ribonucleic Acid Processing and Regulation by Growth Hormone in Extrahepatic TissuesMolecular Endocrinology, 1987
- Growth Hormone Dependence of Somatomedin-C/lnsulin-Like Growth Factor-I and Insulin-Like Growth Factor-ll Messenger Ribonucleic Acids*Molecular Endocrinology, 1987
- Gonadotropins and Estradiol Stimulate Immunoreactive Insulin-Like Growth Factor-I Production by Porcine Granulosa Cells in Vitro*Endocrinology, 1987
- Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides.Journal of Biological Chemistry, 1986
- GROWTH HORMONE INCREASES OVARIAN LEVELS OF IMMONOREACTIVE SOMATOMEDIN C/INSULIN-LIKE GROWTH FACTOR IIN VIVO.Endocrinology, 1986
- Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action.Proceedings of the National Academy of Sciences, 1984